← Browse by Condition
Medical Condition

lca5

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05616793 Phase 1, Phase 2
Recruiting

Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients

Enrollment
22 pts
Location
United States
Sponsor
Opus Genetics, Inc
View Trial →